Ontology highlight
ABSTRACT: Importance
Understanding the characteristics of discordance between plasma biomarkers and positron emission tomography (PET) results in Alzheimer disease (AD) is crucial for accurate interpretation of the findings.Objective
To compare (1) medical comorbidities affecting plasma biomarker concentrations, (2) imaging and clinical features, and (3) cognitive changes between plasma biomarker and PET discordant and concordant cases.Design, setting, and participants
This multicenter cohort study, conducted between 2016 and 2023, included individuals with unimpaired cognition, mild cognitive impairment, or Alzheimer-type dementia, who had both amyloid β (Aβ) PET imaging and plasma biomarkers. A subset of participants also underwent tau PET imaging.Exposures
Particip
SUBMITTER: Yun J
PROVIDER: S-EPMC11833660 | biostudies-literature | 2025 Feb
REPOSITORIES: biostudies-literature